Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cervical|Ovarian|Lung|Breast|Renal
Interventions: DRUG: paclitaxel|DRUG: CBT-1(Registered Trademark)|RADIATION: Tc 99m sestamibi
Sponsor: National Cancer Institute (NCI)